Calcitriol

骨化三醇

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameCalcitriol
Drug Alias Name钙赐吉25D3盖三淳Topitriol罗钙全 +[16] 
ClassificationSmall molecules
Mechanisms of ActionVitamin D receptor agonistsVitamin D analogues
TargetsVitamin D receptor
Therapy Area/IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Attention Deficit Disorder with Hyperactivity +[34] 
Global Approved IndicationsHypoparathyroidismVitamin D DeficiencyHypocalcemia +[6] 
Approved Indications in ChinaVitamin D DeficiencyRenal InsufficiencyChronic Kidney Disease-Mineral and Bone Disorder +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1978/08/17
Country/TerritoryCanadaUnited StatesPakistan +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValidus
China Registration ClassN/A

Develop Information

Active CompaniesRoche Pharma (Switzerland) LtdEsjay Pharma LLCUniversitas Sebelas Maret +[11] 
Inactive CompaniesXiamen Zixu Pharmaceutical Technology Co LtdShireHamad Medical Corporation +[17] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Opioid-Related DisordersCicatrix +[18] 
Inactive IndicationsPlaque psoriasisAttention Deficit Disorder with HyperactivityCocaine-Related Disorders +[16] 

Other Information

ATC CodeA11CC04D05AX03
Related LinksWikipediaDrugBankKEGG